30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Medtronic Initiates Clinical Trial for Infuse Bone Graft in TLIF -

Medtronic commenced site recruitment in a prospective, randomized pivotal clinical trial on the use of Infuse™ Bone Graft in transforaminal lumbar interbody fusion. The trial will potentially enroll over 1,000 subjects at 50 sites. In 2017, MDT received FDA approval of a separate clinical trial to study Infuse in posterolateral fusion (PLF). MDT is enrolling its prospective pilot PLF clinical trial and working with FDA to incorporate retrospective safety and effectiveness data sufficient for indication expansion in PLF. (Medtronic, 9/26/19)